Acrivon Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
480 Arsenal Way Ste 100, Watertown, Mass...Phone Number
(617) 207-8979Website
www.acrivon.comRevenue
$70.4 MillionStock Symbol
ACRVIndustry
About Acrivon Therapeutics
Acrivon is focused on developing best-in-class targeted therapies to enhance the lives of cancer patients through its proprietary AP3 precision medicine platform. The company aims to revolutionize precision oncology by accurately matching drug candidates with patients whose tumors are predicted to be sensitive, thereby improving therapeutic outcomes. Acrivon's pipeline includes advanced programs targeting DNA Damage Response and other critical cancer pathways, with its lead candidate ACR-368 currently in phase 2 clinical development. The company seeks strategic partnerships for co-development and is committed to addressing the world's most pressing cancer challenges.Explore more
Acrivon Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Acrivon Therapeutics
Compare insights from companies similar to Acrivon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Acrivon Therapeutics Tech Stack
A closer look at the technologies used by Acrivon Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acrivon Therapeutics
Sign Up For FreeTo access detailed company insights
Acrivon is focused on developing best-in-class targeted therapies to enhance the lives of cancer patients through its proprietary AP3 precision medicine platform. The company aims to revolutionize precision oncology by accurately matching drug candidates with patients whose tumors are predicted to be sensitive, thereby improving therapeutic outcome... Read More
